Once colon cancer is identified, current European and American guidelines recommend considering extended colorectal surgery for path_MLH1 and path_MSH2 carriers, whereas segmental resection is recommended for path_MSH6 and path_PMS2 carriers. This evidence concerns the gene MSH2 and colonic neoplasm.